Risk management plans can serve as a safeguard, helping manufacturers prepare for and respond to hazards that could lead to drug supply disruptions and shortages
Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery
The company intends to begin using drones to make deliveries of critical and emergency medical supplies, vaccines, and lifesaving drugs after getting the prerequisite regulatory approvals
In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership
The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023
Recognition illustrates Takeda’s patient-centricity throughout its manufacturing and supply processes
Erytech is evaluating valuable strategic options to leverage its Erycaps platform and its development and manufacturing capabilities with complementary assets and/or a broader corporate transaction
This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants
Supply increase to help meet growing global demand
WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility
Subscribe To Our Newsletter & Stay Updated
